StockData

KALA BIO, Inc. (KALA) stock

KALANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 5/30
$3.43−0.40 (-10.44%)

Close on Nov 17, 2026Market cap $66.34MP/E –Yield –

Kala Bio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Kala Bio's price to sales ratio was 6.9× on Apr 28, 2023, against 3.8× a year earlier. Over the last 3 years it ranged from 1.1× to 116.7×, with a median of 15.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Apr 28, 20236.9×−2.9
2022Dec 30, 20229.8×+3.0
2021Dec 31, 20216.8×−64.9
2020Dec 31, 202071.7×–

More Kala Bio figures

See a number that looks wrong?